WINDTREE THERAPEUTICS INC /DE/ Accounts Payable
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Accounts Payable of $1.65 million as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-11-19
- 2025-09-30: Accounts Payable, Current $1.65M.
- 2025-06-30: Accounts Payable, Current $4.12M.
- 2025-03-31: Accounts Payable, Current $3.11M.
- 2024-12-31: Accounts Payable, Current $1.88M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2025-09-30 | $1.65M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $4.12M 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $3.11M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.88M 10-Q · filed 2025-11-19 | |
| 2024-09-30 | $2.05M 10-Q · filed 2024-11-26 | |
| 2024-06-30 | $2.97M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $1.69M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $809.00K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $944.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $964.00K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $753.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $249.00K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $410.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.07M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $724.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $693.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $582.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $288.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $939.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.16M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $726.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.22M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.40M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.71M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $607.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $724.00K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.42M 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $3.42M 10-K · filed 2020-04-03 | |
| 2018-09-30 | $4.52M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $4.26M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $4.68M 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $2.32M 10-K/A · filed 2019-04-23 | $3.05M 10-K · filed 2018-04-17 |
| 2017-09-30 | $3.77M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $2.85M 10-Q · filed 2017-08-21 | |
| 2017-03-31 | $2.31M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.81M 10-K · filed 2018-04-17 | |
| 2016-09-30 | $5.24M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $7.71M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $5.51M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $369.00K 10-K · filed 2017-03-31 | $3.26M 10-K · filed 2016-03-29 |
| 2015-09-30 | $2.46M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $2.31M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $702.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $350.00K 10-K · filed 2016-03-29 | |
| 2014-09-30 | $1.40M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $1.51M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $2.58M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $1.43M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $1.49M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $1.92M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $1.82M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $1.17M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $208.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.33M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.34M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.11M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $1.39M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.99M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $1.69M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |